Hackman, Jeffrey

Insider profile

Performance

Overall performance
3.2

Performance over holding periods
3.2
30 days 90 days 120 days
Average return 13% 8.2% 15.1%
Success rate 100% 68% 82%
Transactions
1 100% Buy
34 71% Buy
47 69% Buy
Hackman, Jeffrey's trades of Fennec Pharmaceuticals Inc's stock


Loading...
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Purchase
Price
481.15
Quantity 21,125 +29.7%
Value US$3,060,936
Transaction date
Purchase
Price
294.99
Quantity 9,080
Value US$1,488,749
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value
Number of shares Price Value Details
2026-10-14 2026-10-12 B Purchase
21,125 +29.7%
481.15
US$3,060,936
21,125 +29.7% 481.15 US$3,060,936
2025-05-19 2025-05-19 B Purchase
9,080
294.99
US$1,488,749
9,080 294.99 US$1,488,749